Hansen L, Hansen T, Vestergaard H, Bjørbaek C, Echwald S M, Clausen J O, Chen Y H, Chen M X, Cohen P T, Pedersen O
Steno Diabetes Center, Copenhagen, Denmark.
Hum Mol Genet. 1995 Aug;4(8):1313-20. doi: 10.1093/hmg/4.8.1313.
The regulatory G-subunit of the glycogen-associated form of protein phosphatase 1 (PP1) plays a crucial part in muscle tissue glycogen synthesis and breakdown. As impaired insulin stimulated glycogen synthesis in peripheral tissues is considered to be a pathogenic factor in subsets of non-insulin-dependent diabetes mellitus (NIDDM) and obesity, the G-subunit of PP1 should be viewed as a candidate gene for inherited insulin resistance. When applying heteroduplex formation analysis and nucleotide sequencing of PP1G-subunit cDNA from 30 insulin resistant white NIDDM patients two cases were identified as heterozygous carriers of an Asp905 --> Tyr substitution. The carrier prevalence of the PP1G-subunit variant was 18% in 150 healthy subjects and 13% in 313 NIDDM subjects (chi 2 = 1.94, p = 0.16). Twenty-seven healthy subjects volunteered for a 4 h euglycaemic, hyperinsulinaemic clamp in combination with indirect calorimetry in order to elucidate the potential impact of the Tyr905 substitution on the whole body glucose metabolism. Interestingly, the Tyr905 variant was associated with altered routing of glucose: a decreased insulin stimulated non-oxidative glucose metabolism of peripheral tissues (glycogen synthesis) (p < 0.04) and an increased basal glucose oxidation rate (p < 0.04) when compared with wild type carriers. A population-based sample of 380 unrelated young healthy Caucasians was examined during a combined intravenous glucose and tolbutamide test to address whether the Asp905/Tyr905 polymorphism was associated with alterations in insulin secretion which might be secondary to the insulin resistance of skeletal muscle.(ABSTRACT TRUNCATED AT 250 WORDS)
蛋白磷酸酶1(PP1)糖原相关形式的调节性G亚基在肌肉组织糖原合成与分解过程中起着关键作用。由于外周组织中胰岛素刺激的糖原合成受损被认为是非胰岛素依赖型糖尿病(NIDDM)和肥胖部分亚型的致病因素,PP1的G亚基应被视为遗传性胰岛素抵抗的候选基因。对30例胰岛素抵抗的白种NIDDM患者的PP1G亚基cDNA进行异源双链形成分析和核苷酸测序时,发现2例为Asp905→Tyr替代的杂合携带者。PP1G亚基变体在150名健康受试者中的携带率为18%,在313名NIDDM受试者中为13%(χ² = 1.94,p = 0.16)。27名健康受试者自愿接受4小时的正常血糖、高胰岛素钳夹试验并结合间接量热法,以阐明Tyr905替代对全身葡萄糖代谢的潜在影响。有趣的是,与野生型携带者相比,Tyr905变体与葡萄糖代谢途径改变有关:外周组织胰岛素刺激的非氧化葡萄糖代谢(糖原合成)降低(p < 0.04),基础葡萄糖氧化率升高(p < 0.04)。在一项联合静脉注射葡萄糖和甲苯磺丁脲试验中,对380名无亲缘关系的年轻健康白种人进行了基于人群的样本检测,以探讨Asp905/Tyr905多态性是否与可能继发于骨骼肌胰岛素抵抗的胰岛素分泌改变有关。(摘要截短于250字)